Next ‐day residual effects of flibanserin on simulated driving performance in premenopausal women

ConclusionsAt both therapeutic and supratherapeutic doses, flibanserin did not impair next‐day driving performance and cognitive function compared to placebo.

Source: Human Psychopharmacology: Clinical and Experimental - May 31, 2017 Category: Psychiatry Authors: Gary G. Kay, Thomas Hochadel, Eric Sicard, Karthi K. Natarajan, Noel N. Kim Tags: RESEARCH ARTICLE Source Type: research